Most Recent
‘Well outside the median range’: Judge questions GCO rate in FleetPartners class action
A judge has expressed concerns about the plaintiff’s proposed group costs order rate in a shareholder class action against fleet management company FleetPartners, saying the purpose of the GCO regime was to lower costs to group members.
Litigation funder hits pay dirt with taxi driver class actions against Uber
The funder behind two class actions against Uber, which have settled for $272 million, stands to make a tidy sum if the settlement holds up at a court approval hearing.
CBA defeats shareholder class actions over money laundering disclosures
Two class actions have failed to convince a judge that the Commonwealth Bank of Australia's money laundering compliance failure which led to a $700 million penalty was "law breaking on a grand scale" that should have been disclosed to the market, the latest shareholder case to flop after being taken to trial.
7-Eleven defeats Seven Network’s opposition to ‘7-Select’ trade mark
Convenience chain 7-Eleven has defeated Seven Network's challenge to its bid to trade mark '7-Select' for a new brand of products targeting younger shoppers, with an IP Australia delegate finding consumer confusion was not likely.
Hitachi denies joint liability with Acciona over guarantees for $511M waste-to-energy plant
Japanese company Hitachi has hit back at a lawsuit filed by the entity in charge of a $511 million waste-to-energy plant in Western Australia which accuses Acciona of withholding $38.6 million in bank guarantees, denying any joint liability with the Spanish infrastructure giant.
Judge OKs $16M Dixon Advisory class action settlement, awards competing funder a sliver
A judge has signed off on a $16 million settlement in a class action against Dixon Advisory, but the funder of a competing case that was stayed after losing a beauty parade has earned a fragment of the $1 million it sought from the resolution sum.
After 7 years of litigation, patent for blockbuster sleep drug Circadin found valid
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.
Acciona hit with second suit over $511M waste-to-energy plant
The entity in charge of a $511 million waste-to-energy plant south of Perth has filed a second lawsuit against Acciona, accusing the Spanish infrastructure giant of withholding $38.6 million in bank guarantees to use as leverage in unrelated disputes about the troubled project.
Not ‘plainly wrong’: NSW appeals court sticks to guns on class closure
The NSW Court of Appeal has said it has no power to exclude group members who do not sign up to a class action from participating in a settlement, upholding a controversial decision that the Full Federal Court said was “plainly wrong”. 
Funder of failed competing class action wants cut of $16M Dixon Advisory settlement
A funder that bankrolled a class action that was stayed against Dixon Advisory has argued it should receive $969,000 from a $16 million settlement reached in the competing proceedings that went ahead, saying its costs were spent to protect group members’ interests.